October 31, 2025 a 11:31 am
📊 ELV: Dividend Analysis - Elevance Health Inc.
Elevance Health Inc., with its strategic dividend approach, demonstrates a stable and consistent dividend history over the past 15 years. Despite a moderate yield of 2.12%, the company's growth and financial prudence signal attractive prospects for income-focused investors. The absence of any recent dividend cuts further enhances the credibility of Elevance's commitment to shareholder returns.
🗣️ Overview
Elevance Health Inc. operates in a robust sector with significant market stability. The current dividend metrics reflect its financial discipline and strategic allocations. A quick summary of core dividend metrics is outlined below:
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Dividend Yield | 2.12% |
| Current Dividend per Share | 6.48 USD |
| Dividend History | 15 years |
| Last Cut or Suspension | None |
📉 Dividend History
The history showcases Elevance's ability to maintain and increase dividends over time, reflecting solid earnings growth and management's commitment to returning capital to shareholders.
| Year | Dividend Per Share (USD) |
|---|---|
| 2025 | 6.84 |
| 2024 | 6.52 |
| 2023 | 5.92 |
| 2022 | 5.12 |
| 2021 | 4.52 |
📈 Dividend Growth
Elevance has delivered a consistent increase in dividends, demonstrated by the growth rates over recent years, aligning with shareholder value creation strategies.
| Time | Growth |
|---|---|
| 3 years | 12.99% |
| 5 years | 15.30% |
The average dividend growth is 15.30% over 5 years. This shows moderate but steady dividend growth.
✅ Payout Ratio
Maintaining a conservative payout ratio is crucial for sustaining future dividend payments and foretelling a company's long-term financial stability.
| Key figure | Ratio |
|---|---|
| EPS-based | 26.43% |
| Free cash flow-based | 38.20% |
The EPS payout ratio of 26.43% and FCF payout ratio of 38.20% indicate that Elevance maintains a balance between reinvesting for growth and rewarding shareholders, a prudent approach valued by investors.
Cashflow & Capital Efficiency
These metrics provide key insights into the company's ability to generate cash relative to its expenses and investments, highlighting operational efficiency and profitability.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Free Cash Flow Yield | 5.30% | 6.16% | 5.89% |
| Earnings Yield | 7.96% | 6.97% | 4.79% |
| CAPEX/Operating Cash Flow | 23.31% | 16.08% | 13.72% |
| Stock-based Compensation/Revenue | 0.12% | 0.17% | 0.17% |
| Free Cash Flow / Operating Cash Flow Ratio | 78.37% | 83.92% | 86.28% |
Elevance demonstrates solid cash flow efficiency and reinvestment capability, marked by robust FCF yields and efficient capital allocations.
Balance Sheet & Leverage Analysis
Understanding balance sheet strength and leverage provides insights into the company’s long-term solvency and risk management.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt-to-Equity | 0.76 | 0.64 | 0.67 |
| Debt-to-Assets | 0.27 | 0.23 | 0.23 |
| Debt-to-Capital | 0.43 | 0.39 | 0.40 |
| Net Debt to EBITDA | 2.19 | 1.77 | 1.65 |
| Current Ratio | 2.01 | 2.05 | 2.05 |
| Quick Ratio | 2.01 | 2.05 | 2.05 |
| Financial Leverage | 2.83 | 2.77 | 2.84 |
Elevance's balance sheet indicates strong leverage management and liquidity, positioning the company for stable future operations.
Fundamental Strength & Profitability
These metrics provide a comprehensive view of the company’s profitability and sustainability, which are critical for long-term investor confidence.
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Return on Equity | 14.47% | 15.23% | 16.26% |
| Return on Assets | 5.12% | 5.50% | 5.74% |
| Margins | |||
| Net | 3.38% | 3.49% | 3.76% |
| EBIT | 5.14% | 5.10% | 5.40% |
| EBITDA | 5.93% | 6.12% | 6.47% |
| Gross | 100% | 100% | 100% |
| Research & Development/Revenue | 0% | 0% | 0% |
The company exhibits consistent profitability and returns, supporting a sustainable growth trajectory and reassuring investors of ongoing value creation.
Price Development
Dividend Scoring System
| Category | Score | Score Bar |
|---|---|---|
| Dividend Yield | 3 | |
| Dividend Stability | 4 | |
| Dividend Growth | 4 | |
| Payout Ratio | 5 | |
| Financial Stability | 4 | |
| Dividend Continuity | 5 | |
| Cashflow Coverage | 4 | |
| Balance Sheet Quality | 5 |
Total Score: 34 out of 40
✅ Rating
In conclusion, Elevance Health Inc. emerges as a fundamentally strong option for dividend-focused investors. Its track record of steady dividend growth, robust payouts, and financial stability underscores a reliable investment opportunity with growth potential. Given the comprehensive assessment, investing in Elevance Health is recommended for those seeking robust dividend returns backed by substantial corporate stability.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years